1. Home
  2. ANVS vs IH Comparison

ANVS vs IH Comparison

Compare ANVS & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$1.83

Market Cap

69.1M

Sector

Health Care

ML Signal

HOLD

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$1.32

Market Cap

70.5M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANVS
IH
Founded
2008
1996
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
69.1M
70.5M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
ANVS
IH
Price
$1.83
$1.32
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$13.50
N/A
AVG Volume (30 Days)
587.3K
3.1K
Earning Date
05-12-2026
03-31-2026
Dividend Yield
N/A
5.88%
EPS Growth
39.39
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$7.30
Revenue Growth
N/A
N/A
52 Week Low
$1.54
$1.28
52 Week High
$5.50
$3.16

Technical Indicators

Market Signals
Indicator
ANVS
IH
Relative Strength Index (RSI) 54.69 46.67
Support Level $1.73 $1.33
Resistance Level $2.02 $1.45
Average True Range (ATR) 0.10 0.03
MACD 0.02 -0.00
Stochastic Oscillator 72.77 41.18

Price Performance

Historical Comparison
ANVS
IH

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.

Share on Social Networks: